bevantolol has been researched along with Arrhythmia in 1 studies
bevantolol: structure given in first source
bevantolol : A propanolamine that is 3-aminopropane-1,2-diol in which the hydrogen of the primary hydroxy group is substituted by 3-methylphenyl and one of the hydrogens attached to the nitrogen is substituted by 2-(3,4-dimethoxyphenyl)ethyl. A beta1 adrenoceptor antagonist, it has been shown to be as effective as other beta-blockers for the treatment of angina pectoris and hypertension.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The drug was associated with a low incidence of adverse experiences similar to that observed with placebo." | 2.66 | Safety profile of bevantolol. ( Bray, JS, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bray, JS | 1 |
1 trial available for bevantolol and Arrhythmia
| Article | Year |
|---|---|
Safety profile of bevantolol.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Clinical Trials as Topic; Double | 1986 |